Nice one Eric!
Where about in Germany are you from?
We should also push for a full Nasdaq listing... this will solve the problem of price discovery due to an ASX listing. I would suggest a european listing however believe the Nasdaq is the best place for biotechs to be listed, at least via a level 3 ADR.
Regards from Sydney!
